Axiora Medical
Axiora Medical
Explore our elite portfolio of reconstruction, spinal, and trauma systems engineered for optimal clinical outcomes.
Hemiarthroplasty remains a cornerstone procedure in orthopedic surgery, particularly for the treatment of displaced femoral neck fractures in the elderly, as well as select cases of avascular necrosis and severe osteoarthritis where the acetabulum remains undamaged. As a global supplier of CE-certified hemiarthroplasty implants, Axiora Medical Technology (China) Co., Ltd. addresses the dual clinical imperatives of biomechanical stability and long-term implant survivability.
Unlike total hip arthroplasty (THA), hemiarthroplasty replaces only the femoral head, preserving the patient's native acetabulum. This design reduces surgical trauma, minimizes dislocation rates, and allows for immediate post-operative weight-bearing. However, it places unique tribological demands on the implant. The metal or ceramic prosthetic head articulates directly against the native articular cartilage of the acetabulum. Therefore, surface roughness, roundness tolerance, and material biocompatibility are critical parameters to prevent cartilage erosion and subsequent groin pain.
To optimize performance, our hemiarthroplasty implants are manufactured using advanced biocompatible alloys, principally Titanium Alloy (Ti6Al4V ELI) and Cobalt-Chromium-Molybdenum (CoCrMo). Cobalt-Chromium-Molybdenum is preferred for the articulating head component due to its high hardness, superior wear resistance, and ability to be polished to an mirror-like finish (roughness Ra < 0.02 μm). The femoral stems are typically produced from Titanium alloy, which exhibits a modulus of elasticity closer to that of human cortical bone, thereby reducing stress shielding and preserving native bone stock.
Modern healthcare systems faces a rising incidence of hip fractures due to aging global demographics. Healthcare providers and medical device distributors require partners who can supply reliable, high-volume orthopedic solutions that reduce total cost of care while maintaining excellent clinical records. Axiora provides integrated implant systems that facilitate standardization in the operating room, reducing instrumentation complexity and surgical steps.
The field of joint reconstruction is rapidly evolving, driven by innovations in digital healthcare, material science, and manufacturing technologies. Axiora is committed to a technical roadmap designed to keep our partners at the forefront of the orthopedic industry.
Operating a modern 18,600 m² facility, Axiora implements Factory 4.0 paradigms to deliver consistent, cost-effective product lines. By integrating robotic CNC milling, automated anodizing, and multi-stage ultrasonic cleaning systems, we guarantee high dimensional repeatability and minimize human error. This technological core allows us to scale manufacturing rapidly while maintaining cost-competitive OEM/ODM pricing, ensuring our global buyers retain a strong competitive advantage in tender bidding and private labeling.
Axiora Medical Technology (China) Co., Ltd. is a leading name in orthopedic implant manufacturing, supplying distributors and hospital groups globally.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
| Item | Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 |
| Factory Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Partners | 1,120 |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 |
| R&D Engineers | 86 |
Navigating global regulatory landscapes for orthopedic implants demands deep expertise and reliable trace documentation. Axiora maintains fully localized customer service networks and regulatory compliance agents across multiple geographic territories. For our distribution partners in Europe and South America, we supply extensive regulatory dossiers, including full biocompatibility studies, mechanical fatigue test logs (adhering to ISO 7206 guidelines), and sterilization validation reports.
Our commitment goes beyond simply shipping medical components. We provide full lifecycle OEM and ODM support, translating client blueprints and requirements into clinical-grade implants. Using CMM dimension audits, optical roughness checks, and penetrant crack testing, we guarantee that every batch meets the exact mechanical integrity criteria demanded by modern surgical suites.
Key technical inquiries concerning manufacturing, certification, and procurement parameters.
Providing hospital-grade fixation plates, veterinary instruments, and surgical repair systems.
